Intensive long-term intravenous iron-chelation therapy with deferoxamine in thalassemic patients.
Department of Haematology, University of Tor Vergata, Rome.
P
P
Cianciulli
L
L
Forte
F
F
Sorrentino
M
M
Palombi
G
G
Papa
M G
MG
Marciani
D000328:Adult; D000410:Alanine Transaminase / Q000097:blood; D002408:Catheters, Indwelling; D015913:Chelation Therapy; D003676:Deferoxamine / Q000008:administration & dosage* / Q000627:therapeutic use; D005069:Evaluation Studies as Topic; D005260:Female; D005293:Ferritins / Q000097:blood; D006801:Humans; D007260:Infusion Pumps; D007262:Infusions, Intravenous / Q000295:instrumentation; D007501:Iron / Q000652:urine; D008297:Male; D013318:Stroke Volume; D017086:beta-Thalassemia / Q000188:drug therapy*
D005293:Ferritins; D007501:Iron; D000410:Alanine Transaminase; D003676:Deferoxamine